Fujifilm to accelerate the manufacturing of Avigan to treat COVID-19

By Akshay Kedari  | Date: 2020-04-16

Fujifilm to accelerate the manufacturing of Avigan to treat COVID-19

Fujifilm, a renowned Japanese pharmaceutical company, has reportedly announced plans to boost the production of Avigan, an antiviral drug said to be a possible therapy for coronavirus. Avigan is primarily used to treat Influenza.

The company is aiming to provide this drug in large quantities in order to meet the nationwide growing need for antiviral drugs. The company hopes to produce hundreds of thousands of Avigan doses during the coming months.

The drug maker is currently increasing its production capacity in its Toyoma facility to accelerate the production rate. Since the company is planning large-scale production for Avigan, it has created strategic collaborations with international and domestic firms to provide the raw material for manufacturing Avigan and has also added capacity at its Mako Pure Chemical Co. unit to manufacture active pharmaceutical ingredients of the drug.

Since Fujifilm will now have its massive production in place, it is expecting to produce 100,000 Avigan treatments courses ready for use by July. This number of 3.5 times Avigan’s supply in March and the company has further plans to manufacture 300,000 regimens in place by September.

Japanese drug maker, last month, stated its intentions to accelerate the production of Avigan, after the news made a global impact. However, the company also made some clarifications about its use. The company particularly specified that the Influenza treatment drug has never been distributed in any market and that it is not available in any pharmacies and hospitals across Japan as well as overseas.

Avigan is an antiviral drug developed by the Toyama Chemical unit of Fujifilm and it received approval for sale back in 2014 to treat influenza. However, it was told that this drug can only be used when all other treatments turn out to be ineffective against a re-emerging or novel influenza virus.

While talking about this drug, Shinzo Abe, the Prime Minister of Japan stated that the government would soon initiate tests of Avigan in coronavirus patients in collaboration with other nations and simultaneously accelerate the production while aiming a faster approval for the drug.

Source credit: https://www.fiercepharma.com/manufacturing/fujifilm-speeds-production-potential-covid-19-therapy-avigan

About Author

Akshay Kedari     aeresearch.net

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More >>

More News By Akshay Kedari

Fitbit faces privacy complaints in EU over alleged unlawful data exports

Fitbit faces privacy complaints in EU over alleged unlawful data exports

By Akshay Kedari

Fitbit, a Google company, is reportedly facing a series of privacy complaints within the European Union. These complaints revolve around allegations that the company is engaging in unlawful exporting of user data, thereby violating the EU's strin...

Social network X makes API changes impacting developers & enterprise clients

Social network X makes API changes impacting developers & enterprise clients

By Akshay Kedari

Social network X, previously known as Twitter, has reportedly unveiled more modifications that involve the retirement of certain legacy API endpoints. The company implemented adjustments to its API pricing in March, resulting in elevated costs for...

Zapata AI and IonQ joins hands to push boundaries of Generative AI

Zapata AI and IonQ joins hands to push boundaries of Generative AI

By Akshay Kedari

Zapata AI, a software enterprise dedicated to addressing intricate computational challenges, has reportedly unveiled a strategic partnership with IonQ, a leading figure in quantum computing hardware and commercial quantum application advancement. The...

Meta unveils AudioCraft for audio & music creation using Generative AI

Meta unveils AudioCraft for audio & music creation using Generative AI

By Akshay Kedari

The tech giant Meta has reportedly introduced AudioCraft, a framework capable of generating high-quality audio and music based on short text prompts. The AudioCraft framework aims to simplify the use of generative models for audio by providing a c...

GSK Pharma reports 11% surge in Q1 profit fueled by Vaccine Demand

GSK Pharma reports 11% surge in Q1 profit fueled by Vaccine Demand

By Akshay Kedari

GlaxoSmithKline Pharmaceuticals, the Indian arm of GSK plc based in the UK, reportedly recorded an 11% increase in its first-quarter profit, driven by robust demand for its vaccines. According to the company's statement, the consolidated profi...